Valeant continues debt slicing with $190m Obagi sale

By Mohammed Mestar

Pharma giant Valeant has confirmed the $190m sale of its skin-care product business Obagi - just four years after it bought the company.

The Laval-based firm has agreed the deal to hand Obagi over to the Haitong International Zhonghua Finance Acquisition Fund.

It is the latest in a line of sales from Valeant as it looks to reduce its $29bn debt that was created under the rocky leadership of previous CEO Mike Pearson.

Last week it announced the sale of its cancer treatment unit Dendreon Pharmaceuticals for $811m, while in June it confirmed a $930m deal for the handover of its iNova Pharmaceuticals business to a company owned jointly by Pacific Equity Partners and The Carlyle Group.

See also: 


Valeant bought Obagi in 2013 for $344m but has now cuts its losses on its business that creates products to help minimize the appearance of premature skin aging, skin damage and hyperpigmentation.

"The sale of Obagi marks additional progress in our efforts to streamline our operations and reduce debt," said Joseph C. Papa, chairman and CEO of Valeant. 

"As we continue to transform Valeant, we will remain focused on the core businesses that will drive high value for our shareholders."

The transaction is expected to close in the second half of 2017.

Share

Featured Articles

Top 10 must-read sustainable leadership books for CEOs

As former Unilever boss Paul Polman debuts his new net zero book, we ask – can profit and purpose truly exist? Here are 10 business books to prove they can

Top 20 essential leadership resources for Black executives

To celebrate Black History Month, here are 20 resources for Black leaders – from business books to leadership coaches to business school exec programs

Broadridge study reveals huge impact of AI on C-suite

Broadridge Financial Solutions spoke to 500 C-suite executives from across the globe, many of whom said AI was significantly changing the way they work

PwC's Kathryn Kaminsky – the role of boards on social issues

Leadership & Strategy

Why your business needs a Chief Transformation Officer

Leadership & Strategy

12 top AI and ML trends for the enterprise in 2023 – Dataiku

Technology & AI